EXPERIMENTAL AND MOLECULAR MEDICINE
Scope & Guideline
Elevating biomedical knowledge through peer-reviewed excellence.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
Focuses on the molecular pathways involved in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases, providing insights into potential therapeutic targets. - Experimental Models and Techniques:
Utilizes diverse experimental models, including organoid systems, animal models, and advanced imaging techniques, to investigate disease mechanisms and test therapeutic interventions. - Translational Research:
Emphasizes the translation of laboratory findings into clinical applications, bridging the gap between basic science and clinical practice, particularly in oncology and regenerative medicine. - Immunology and Inflammation:
Explores the roles of immune responses and inflammation in disease progression and therapy, with a focus on therapeutic strategies that modulate immune pathways. - Genomics and Epigenetics:
Investigates the impact of genomic and epigenetic alterations on disease development and progression, employing cutting-edge sequencing technologies to elucidate complex biological processes. - Microbiome and Disease Interactions:
Examines the interactions between the microbiome and host physiology, particularly how these interactions influence disease states and therapeutic outcomes. - Advanced Therapeutics and Drug Development:
Covers innovative approaches in drug discovery, including the development of novel therapeutic agents, biomarker identification, and personalized medicine strategies.
Trending and Emerging
- Organoid Technology and Applications:
The use of organoids as models for disease research is rapidly expanding, allowing for more accurate studies of human physiology and disease mechanisms, as well as drug testing. - Targeted Cancer Therapies:
There is a growing focus on developing targeted therapies that exploit specific molecular pathways in cancer, reflecting advances in precision medicine. - RNA Biology and Therapeutics:
Research on the roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is trending, with implications for cancer therapy and gene regulation. - Immunotherapy and Immune Modulation:
The exploration of novel immunotherapeutic strategies, including the manipulation of immune pathways and the development of immune checkpoint inhibitors, is gaining momentum. - Metabolic Reprogramming in Disease:
Research into how metabolic changes affect disease progression, particularly in cancer and metabolic disorders, is emerging as a critical area of study. - Microbiome Research and Health:
The investigation of the microbiome's role in health and disease is increasingly prominent, with implications for therapeutic interventions and understanding disease mechanisms. - Epigenetics and Disease:
The study of epigenetic modifications and their impact on gene expression and disease development is on the rise, highlighting the complexity of genetic regulation.
Declining or Waning
- Traditional Pharmacology:
Research focused on classical pharmacological approaches is less prevalent, as more emphasis is placed on targeted therapies and personalized medicine. - Basic Biochemistry:
While foundational biochemistry remains important, there is a noticeable shift towards more complex systems biology and molecular mechanisms, leading to a decline in studies centered solely on basic biochemical processes. - In vitro Cell Culture Studies:
The reliance on conventional in vitro studies has decreased, with a growing preference for more sophisticated models, such as organoids and 3D cultures, which better mimic in vivo conditions. - Animal Models of Disease:
The use of traditional animal models is declining in favor of more innovative and relevant models that can better replicate human disease mechanisms and responses to treatments. - Single Biomarker Studies:
Research focusing on single biomarkers is becoming less common as the field shifts towards integrative approaches that consider multiple factors and interactions within biological systems.
Similar Journals
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Illuminating the Pathways of Molecular MedicineBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
Advancing the Frontiers of Biological and Medical ResearchBULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.
EXPERIMENTAL AND MOLECULAR PATHOLOGY
Advancing the frontiers of disease understanding.EXPERIMENTAL AND MOLECULAR PATHOLOGY, a distinguished journal published by Academic Press Inc Elsevier Science, is recognized for its significant contributions to the fields of pathology, clinical biochemistry, and molecular biology. With an ISSN of 0014-4800 and an E-ISSN of 1096-0945, this journal provides a platform for the dissemination of high-quality research articles, reviews, and experimental studies that deepen our understanding of disease mechanisms and diagnostic pathways. Since its inception in 1962 and through its converged publication years, the journal has consistently maintained a solid impact in the academic community, achieving high Scopus rankings—ranked #15 in the field of Pathology and Forensic Medicine and #22 in Clinical Biochemistry, showcasing a commendable percentile standing of 93rd and 81st respectively in 2023. The journal is accessible through various academic libraries and institutional subscriptions, making it an essential resource for researchers, professionals, and students committed to advancing knowledge in these critical areas. With a categorization that includes Q1 rankings in Pathology and Forensic Medicine, EXPERIMENTAL AND MOLECULAR PATHOLOGY stands as a prominent venue for pioneering scientific inquiry and collaborative advancement in molecular diagnostics and therapeutic strategies.
MOLECULES AND CELLS
Illuminating the Path of Molecular DiscoveryMOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.
Biomolecules and Biomedicine
Unlocking the Secrets of Biomolecules for Better HealthBiomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.
Frontiers in Molecular Biosciences
Exploring the Frontiers of Molecular BiologyFrontiers in Molecular Biosciences is an esteemed open-access journal published by FRONTIERS MEDIA SA, based in Switzerland. Since its inception in 2014, the journal has made significant strides in the fields of biochemistry, genetics, and molecular biology, cementing its reputation with a solid position in the Q1 quartile for both Biochemistry and Genetics and Molecular Biology (miscellaneous) categories as of 2023. With a remarkable Scopus rank of #14/103 in the combined categories, it offers an essential platform for the dissemination of high-quality research that shapes the understanding of molecular processes and their implications in health and disease. The journal’s commitment to open access facilitates the broadest possible reach for groundbreaking discoveries, serving as a vital resource for researchers, professionals, and students alike. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, this journal continues to foster innovative discussions and advancements in molecular biosciences, paving the way for new insights and collaborations in the scientific community.
FASEB BioAdvances
Exploring Breakthroughs in Biological ResearchFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
Physiology and Pharmacology
Innovating the understanding of physiology and pharmacology.Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.
Molecular Medicine Reports
Transforming Research into Real-World ApplicationsMolecular Medicine Reports, an esteemed academic journal published by Spandidos Publications Ltd, serves as a vital platform for the dissemination of cutting-edge research in the field of molecular medicine. Established in 2008, this journal has rapidly ascended in prominence, currently positioned within the Q2 and Q3 quartiles across various critical categories including Biochemistry, Cancer Research, and Genetics, reflecting its significant impact and scholarly contributions. With an impressive Scopus ranking in multiple disciplines, including an 87th place in Oncology, it is recognized for publishing rigorous, peer-reviewed articles that bridge the gap between laboratory research and clinical applications. The journal’s commitment to advancing knowledge in molecular medicine is evident through its focus on innovative therapeutic approaches, genetic research, and oncological studies, catering to a diverse readership of researchers, professionals, and students in the biomedical field. Though not an open-access publication, it provides invaluable insights and fosters collaboration in the scientific community from its base in Athens, Greece.
Animal Models and Experimental Medicine
Bridging laboratory insights with clinical breakthroughs.Animal Models and Experimental Medicine is a prestigious open-access journal published by WILEY that has been a significant contribution to the field of biomedical research since its inception in 2018. Focusing on the role of animal models in the exploration of experimental medicine, the journal has garnered attention for its rigorous peer-reviewed articles that bridge laboratory research with clinical applications. The journal currently holds impressive quartile rankings, including Q1 in Medical Laboratory Technology, Veterinary (miscellaneous), and strong standings across various other categories, reflecting its reputable position within the Scopus rankings. With a commitment to disseminating high-quality research that advances knowledge and practice in veterinary and medical sciences, Animal Models and Experimental Medicine offers a platform for researchers, professionals, and students to contribute to and stay informed about pivotal developments in the field. As an open-access journal, it ensures accessibility, encouraging a wider readership and fostering collaboration among the scientific community.